201 related articles for article (PubMed ID: 36348479)
1. Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study.
Wadsworth E; Fataar F; Goodman S; Smith DM; Renard J; Gabrys R; Jesseman R; Hammond D
BMC Public Health; 2022 Nov; 22(1):2048. PubMed ID: 36348479
[TBL] [Abstract][Full Text] [Related]
2. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
[TBL] [Abstract][Full Text] [Related]
3. Consumer perceptions of 'legal' and 'illegal' cannabis in US states with legal cannabis sales.
Fataar F; Goodman S; Wadsworth E; Hammond D
Addict Behav; 2021 Jan; 112():106563. PubMed ID: 32768793
[TBL] [Abstract][Full Text] [Related]
4. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
Wadsworth E; Driezen P; Pacula RL; Hammond D
Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
[TBL] [Abstract][Full Text] [Related]
5. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020.
Goodman S; Wadsworth E; Hammond D
J Stud Alcohol Drugs; 2022 May; 83(3):392-401. PubMed ID: 35590180
[TBL] [Abstract][Full Text] [Related]
6. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization.
Wadsworth E; Driezen P; Chan G; Hall W; Hammond D
Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544
[No Abstract] [Full Text] [Related]
7. Retail availability and legal purchases of dried flower in Canada post-legalization.
Wadsworth E; Driezen P; Hammond D
Drug Alcohol Depend; 2021 Aug; 225():108794. PubMed ID: 34098382
[TBL] [Abstract][Full Text] [Related]
8. Noticing of cannabis health warning labels in Canada and the US.
Goodman S; Hammond D
Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418
[TBL] [Abstract][Full Text] [Related]
9. Proximity to Legal Cannabis Stores in Canada and Use of Cannabis Sources in the First Three Years of Legalization, 2019-2021.
Wadsworth E; Driezen P; Dilley JA; Gabrys R; Jesseman R; Hammond D
J Stud Alcohol Drugs; 2023 Nov; 84(6):852-862. PubMed ID: 37306374
[TBL] [Abstract][Full Text] [Related]
10. Home cultivation across Canadian provinces after cannabis legalization.
Wadsworth E; Cristiano N; Pacheco K; Jesseman R; Hammond D
Addict Behav Rep; 2022 Jun; 15():100423. PubMed ID: 35434251
[TBL] [Abstract][Full Text] [Related]
11. Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.
Lineham J; Wadsworth E; Hammond D
Drug Alcohol Rev; 2023 Jul; 42(5):1142-1152. PubMed ID: 37062952
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of cannabis use and the frequency, types, and sources of cannabis products used in northern remote territories of the Canadian legal cannabis market.
Hobin E; Schwartz N; Poon T; Hammond D
Can J Public Health; 2024 May; ():. PubMed ID: 38760617
[TBL] [Abstract][Full Text] [Related]
13. Do Mandatory Health Warning Labels on Consumer Products Increase Recall of the Health Risks of Cannabis?
Goodman S; Leos-Toro C; Hammond D
Subst Use Misuse; 2022; 57(4):569-580. PubMed ID: 34989662
[TBL] [Abstract][Full Text] [Related]
14. Co-Use, Simultaneous Use, and Mixing of Cannabis and Tobacco: A Cross-National Comparison of Canada and the US by Cannabis Administration Type.
Chu A; Chaiton M; Kaufman P; Goodwin RD; Lin J; Hindocha C; Goodman S; Hammond D
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901216
[TBL] [Abstract][Full Text] [Related]
15. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
[No Abstract] [Full Text] [Related]
16. Co-use of cannabis and alcohol before and after Canada legalized nonmedical cannabis: A repeat cross-sectional study.
Hobin E; Weerasinghe A; Boniface S; Englund A; Wadsworth E; Hammond D
J Psychopharmacol; 2023 May; 37(5):462-471. PubMed ID: 37039435
[TBL] [Abstract][Full Text] [Related]
17. Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States.
Wadsworth E; Hines LA; Hammond D
Subst Abus; 2022; 43(1):943-948. PubMed ID: 35420977
[No Abstract] [Full Text] [Related]
18. Perceptions of cannabis use risk to mental health among youth in Canada, England and the United States from 2017 to 2021.
Lemos MK; Taylor E; Wadsworth E; Reid JL; Hammond D; East K
Drug Alcohol Depend; 2023 Sep; 250():110904. PubMed ID: 37549543
[TBL] [Abstract][Full Text] [Related]
19. Out-of-state cannabis purchases in the United States.
Wadsworth E; Hammond D
Drug Alcohol Depend; 2020 Feb; 207():107822. PubMed ID: 31911336
[TBL] [Abstract][Full Text] [Related]
20. How have cannabis use and related indicators changed since legalization of cannabis for non-medical purposes? Results of the Canadian Cannabis Survey 2018-2022.
Goodman S; Dann MJ; Fataar F; Abramovici H
Int J Drug Policy; 2024 May; 127():104385. PubMed ID: 38520961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
